Navigation Links
Pharmaceutical sciences experts present cutting-edge research at international meeting
Date:9/28/2010

Arlington, Va. (Sept. 27, 2010) -- Renowned international experts and scientists will present new research ranging from inhalable vaccines for human papillomavirus and tuberculosis to a non-invasive treatment for lung cancer at the 2010 FIP Pharmaceutical Sciences World Congress (PSWC) in association with the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in New Orleans, La., Nov. 14-18.

For the first time, the International Pharmaceutical Federation's (FIP) PSWC and AAPS will join forces and hold the world's largest pharmaceutical sciences meeting to share perspectives, ideas and research to improve global health through advances in pharmaceutical sciences. An estimated 10,000 scientists from more than 60 countries will participate in more than 100 sessions, including 40 symposia and roundtables.

Other meeting highlights include:

  • A keynote address by Dr. Tadataka "Tachi" Yamada, president of the Bill & Melinda Gates Foundation Global Health Program, who will discuss the future of global health;

  • A three-part symposium, "Pharmaceuticals without Borders" that focuses on delivering medicines to underserved populations, regulatory and supply chain challenges, and ensuring integrity and quality of medicines;

  • Symposia on current anti-counterfeiting strategies; and

  • Symposia on bridging the gap between traditional medicine and the Western approach to natural products.


'/>"/>

Contact: Hillarie Turner
hbt@ecius.net
202-296-2002 x113
American Association of Pharmaceutical Scientists
Source:Eurekalert

Page: 1

Related biology news :

1. Chemist to donate potential pharmaceutical royalties to Madagascar
2. Donation for new Center for Pharmaceutical Nanotechnology and Nanotoxicology
3. Anadys Pharmaceuticals to Present at the Roth OC Growth Stock Conference
4. Simulating pharmaceutical and personal care product transport
5. Researchers prolong the half-life of biopharmaceutical proteins
6. InVivo and CEVEC pharmaceuticals sign license agreement regarding the use of human CAP-T Technology for production of recombinant proteins
7. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
8. TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services
9. NIH awards $8.5 million for research on pharmaceuticals for children
10. Biostar Pharmaceuticals, Inc. Receives New Advertising Approval from Shaanxi SFDA for Marketing Xin Aoxing Capsule
11. ACS Green Chemistry Institute Pharmaceutical Roundtable award goes to Scottish chemist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... , November 22, 2016 According to the new ... Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function ... by MarketsandMarkets, the market is expected to grow from USD 10.74 Billion ... of 16.79% between 2016 and 2022. Continue ... ...
(Date:11/17/2016)... -- AIC announces that it has just released a new white paper authored by Zettar ... high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be ...
(Date:11/14/2016)... , Nov. 14, 2016  Based on ... market, Frost & Sullivan recognizes FST Biometrics ... Award for Visionary Innovation Leadership. FST Biometrics ... biometric identification market by pioneering In Motion ... for instant, seamless, and non-invasive verification. This ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... This report analyzes the worldwide markets for Biostimulants ... Amino, & Fulvic), Extract Based, and Others. The report also ... & Turf, Row Crops, and Others. The report provides separate ... Japan , Europe , ... , and Rest of World. Annual estimates and forecasts are ...
(Date:12/8/2016)... 8, 2016  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... intratumoral cancer immunotherapies, today announced financial results for ... "We are delivering on our commitment to address ... IL-12. We are pleased with the early clinical ... and we are focused on advancing our lead ...
(Date:12/8/2016)... PUNE, India , December 8, 2016 ... is a comprehensive analysis, titled Global Amyloglucosidase Industry 2016 Market ... definition, classification, application, and industry chain overview are all covered ... project SWOT analysis, and investment return analysis of the Amyloglucosidase ... , , ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire-USNewswire/ ... treatments for congestive heart failure and type 2 ... license for a novel adeno-associated virus (AAV) vector ... Kay , M.D., Ph.D., at Stanford University. The ... of its paracrine gene therapy product pipeline. ...
Breaking Biology Technology: